Oamic holds 5 PCT international patents, 13 Chinese patents, 3 US patents and 3 European patents.


Our goal is to acquire more than 10 patents per year.



Oamic’s innovative technology of the biosynthesis of vanillin via ferulic acid has achieved global leadership. In addition, we have pioneered a number of innovative technology, including the manufacture of natural chiral lactones and many other special products.


We invested $2.5 million to introduce a glycerine derivative technology from Inventure Renewables Inc. of the United States. The use of glycerol intermediates, combined with our downstream process, will greatly improve the production process of a series of pharmaceutical products, reducing more than 95% of the production pollution. This gives our products a considerable cost advantage.



We believe that evolutionary thinking can bring us more innovation!


{ganrao} 网上股票配资平台安全吗 北京pk拾赛车是正规的彩票吗 北京快中彩玩法说明 3d试机号关注码是 财神到配资 网络投资理财平台 东方财富上证指数行情 青海十一选五中奖规则 419彩票网站 江西多乐彩论坛 11229期排列3开奖 股票涨跌周期图 十一选五开奖结果天津 山西省十一选五最牛 中国3d福利彩票 乐彩快乐十分群